These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22264760)

  • 1. Tools and methodologies capable of isolating and identifying a target molecule for a bioactive compound.
    Sakamoto S; Hatakeyama M; Ito T; Handa H
    Bioorg Med Chem; 2012 Mar; 20(6):1990-2001. PubMed ID: 22264760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the mode of action of bioactive compounds.
    Azad MA; Wright GD
    Bioorg Med Chem; 2012 Mar; 20(6):1929-39. PubMed ID: 22300885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical target isolation for novices: affinity-based strategies.
    Sato S; Murata A; Shirakawa T; Uesugi M
    Chem Biol; 2010 Jun; 17(6):616-23. PubMed ID: 20609411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of bioactive small molecule target through phenotypic screening.
    Cho YS; Kwon HJ
    Bioorg Med Chem; 2012 Mar; 20(6):1922-8. PubMed ID: 22153994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and application of high-performance affinity beads: toward chemical biology and drug discovery.
    Sakamoto S; Kabe Y; Hatakeyama M; Yamaguchi Y; Handa H
    Chem Rec; 2009; 9(1):66-85. PubMed ID: 19243077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target identification of small molecules based on chemical biology approaches.
    Futamura Y; Muroi M; Osada H
    Mol Biosyst; 2013 May; 9(5):897-914. PubMed ID: 23354001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target identification of bioactive compounds.
    Tashiro E; Imoto M
    Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic methods for drug target discovery.
    Sleno L; Emili A
    Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug target deconvolution by chemical proteomics.
    Raida M
    Curr Opin Chem Biol; 2011 Aug; 15(4):570-5. PubMed ID: 21763176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry.
    Calleri E; Temporini C; Caccialanza G; Massolini G
    ChemMedChem; 2009 Jun; 4(6):905-16. PubMed ID: 19378293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weak affinity chromatography for evaluation of stereoisomers in early drug discovery.
    Duong-Thi MD; Bergström M; Fex T; Svensson S; Ohlson S; Isaksson R
    J Biomol Screen; 2013 Jul; 18(6):748-55. PubMed ID: 23479356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound immobilization and drug-affinity chromatography.
    Rix U; Gridling M; Superti-Furga G
    Methods Mol Biol; 2012; 803():25-38. PubMed ID: 22065216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
    Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
    J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry-based functional proteomics for drug target deconvolution.
    Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
    Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward high-throughput drug screening on a chip-based parallel affinity separation platform.
    Ohlson S; Duong-Thi MD; Bergström M; Fex T; Hansson L; Pedersen L; Guazotti S; Isaksson R
    J Sep Sci; 2010 Sep; 33(17-18):2575-81. PubMed ID: 20730836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-based protein profiling for natural product target discovery.
    Krysiak J; Breinbauer R
    Top Curr Chem; 2012; 324():43-84. PubMed ID: 22025071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography data.
    Bender A; Mikhailov D; Glick M; Scheiber J; Davies JW; Cleaver S; Marshall S; Tallarico JA; Harrington E; Cornella-Taracido I; Jenkins JL
    J Proteome Res; 2009 May; 8(5):2575-85. PubMed ID: 19271732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.